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Abstract
The mission of NASA's Human Research Program (HRP) is to understand and
reduce the risk to crew health and performance in exploration missions. The
HRP addresses 27 specific risks1, primarily in the context of Continuous Risk
Management. Each risk is evaluated in terms of two missions (a six month
stay on the Moon and a thirty month round trip to Mars) and three types of
consequences (in-mission crew health, in-mission performance, and post-
mission crew health). The lack of a common metric between the three
consequence categories, such as financial costs or quality adjusted life years
lost, makes it difficult to compare the relative criticality of the risks. We are,
therefore, exploring the use of a ternary metric of criticality based on the
common metric of influencing an operational decision. The three levels
correspond to the level of concern the risk generates for a "go/no-go“
decision to launch a mission: 1) no-go; 2) go with significant reservations; 3)
go. The criticality of each of the 27 risks is scored for the three types of
consequence in both types of mission. The scores are combined to produce
an overall criticality rating for each risk. The overall criticality rating can then
be used to guide the prioritization of resources to affect the greatest
amount of risk reduction.
Mission Types
Moon- 4-person crews, 180 days Mars- 6-person crews, up to 1000 days
Consequence Types
The Office of the Chief Health and Medical Officer at NASA is concerned
with three types of consequences:
1. Short Term Health- during the mission and within one year of
return.
2. In-Mission Performance- the ability of the crew to perform
mission tasks
3. Long Term Health- one year after return and later.
Metrics can be readily developed for each type of consequence. Sick days,
mission objectives accomplished, quality adjusted life years lost are
examples. It is more difficult to identify a metric, however, that applies to all
three types of consequence.
A Common Metric: The Criticality Metric
Before a space flight mission is launched, several organizations within NASA 
are polled for a “Go/No-Go” status. The Office of the Chief Health and 
Medical Officer is one such organization. A common metric, then, between 
the three types of consequence of concern to OCHMO is the impact of a 
risk’s status on the “Go/No-Go”  recommendation. This metric consists of 
three values:
• Critical- Absence of additional data or risk mitigation countermeasures 
would likely delay Lunar Outpost or Mars Missions, even if all other 
elements of the mission were ready (e.g., if the launch systems, 
Extravehicular Activity (EVA) systems, landing and life support systems were 
ready). The lack of this data or an adequate additional mitigation would 
leave NASA with unacceptable uncertainty in the  risk, and/or with 
unacceptable absolute risk to human health and performance, thus 
precluding NASA’s ability to embark on the mission.  
• Important- Absence of additional data or risk mitigation countermeasures 
in this area would likely not delay lunar outpost or Mars missions, if all other 
elements of the mission were ready. This would leave the mission with 
significant  or unknown risk, however. Mission loss or major impact to crew 
health (in-mission or post-mission) could occur if this risk is not quantified 
and reduced.  
• Desirable- The absence of data or risk mitigation countermeasures in this 
area would not delay the lunar outpost or Mars missions if all other 
elements of the mission were ready. However, quantifying the risk and 
implementing risk mitigation strategies could reduce the risk for that 
particular discipline. Engineering or operational workarounds/ constraints 
could be avoided if this risk were quantified and/or reduced. 
The HRP has used this metric in its Integrated Research Plan2. Each risk is 
scored on this metric, once for the lunar mission and once for the martian
mission. The IRP mission scores are officially approved by the HRP.
For this work, a more detailed scoring was conducted. Each risk was scored 
for each type of consequence within the mission type (Table 1) such that at 
least one score equaled the IRP mission score and none exceeded the IRP 
mission score. These scores are not officially approved by the HRP.
Example: the risk of inability to treat an ill or injured crew member.
C
I
D Comparing Risks: The Criticality Score
The Criticality Score, CS, for each risk is the sum of weights (Table 2) over 
each mission type (lunar and martian) and consequence type (STH, IMP, 
and LTH). For example, the CS of the risk of inability to treat an ill or injured 
crew member is 1 + 1 + 0.1 + 10 + 10 + 0.1 = 22.2
Table 2
For simplicity in this work, the lunar and martian missions were weighted 
equally (Table 2).
This weighting scheme allows the Criticality Score to reflect the rank order 
criticality of the risks with the assumption that no number of Desirable 
scores can equal or exceed an Important score and no number of Important 
scores can equal or exceed a Critical score.
The Criticality Scores are depicted in Figure 1 (linear scale) and Figure 2 
(logarithmic scale).
Discussion
This approach provides a basis for comparing the 27 risks being addressed 
by the HRP.
The Criticality Score, CS, allows risks to be rank ordered based on their 
relative importance to the missions (Moon or Mars) and types of 
consequences (short term health, in-mission performance, or long term 
health).  Arithmetic operations on the CS (e.g., addition, multiplication) to 
calculate quantities such as averages are not meaningful.
The rank ordering and graphical display provide an overall view of the risks: 
the degree of total criticality, the relative contribution from the different 
missions, groupings of comparable criticality. It provides a qualitative tool 
for the risk manager to analyze the portfolio of risks and to guide the 
allocation of resources to control the risks.
The CS guides, but does not dictate, funding priorities. The cost per unit risk 
reduction and the timeframe in which the risk must be addressed are 
among the other factors that must be considered for funding priorities.
The current approach provides a common metric for consequences of 
interest to NASA’s Office of the Chief Health and Medical Officer. However, 
it does address not another important goal of HRP: reduce human systems 
resource requirements (mass, volume, power, data, etc.). The resource 
savings can be achieved in design phases as well as operational phases. An 
even broader metric is required to enfold the need to reduce resource 
requirements.
The risks for the martian mission are more critical than the lunar missions. 
The only lunar mission risk with a criticality comparable to martian mission 
criticality is the risk of radiation carcinogenesis.
Conclusion
The Criticality metric described here provides a useful tool for making rank 
order comparisons  between risks using risk properties of interest to NASA’s 
Office of the Chief Health and Medical Officer.
References
1. PRD
2. IRP
STH IMP LTH STH IMP LTH
Critical 10.0       10.0       10.0       10.0       10.0       10.0       
Important 1.0         1.0         1.0         1.0         1.0         1.0         
Desirable 0.1         0.1         0.1         0.1         0.1         0.1         
Weighting
Lunar Martian
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Risk/Risk Factor of: STH IMP LTH STH2 IMP2 LTH2
Acute or Late Central Nervous System Effects from Radiation Exposure I I I C C C
Inability to Adequately Treat an Ill or Injured Crew Member I I D C C D
Behavioral and Psychiatric Conditions D D D C C D
Inadequate Nutrition D D D C C D
Inadequate Food System D D D C C D
Radiation Carcinogenesis D D C D D C
Reduced Physical Performance Capabilities Due to Reduced Aerobic Capacity D I D D C D
Impaired Performance Due to Reduced Muscle Mass, Strength and Endurance D I D D C D
Degenerative Tissue or other Health Effects from Radiation Exposure D D I D D C
Acute Radiation Syndromes Due to Solar Particle Events I I D I I D
Compromised EVA Performance and Crew Health Due to Inadequate EVA Suit Systems D I D I I D
Intervertebral Disc Damage D D D I I D
Cardiac Rhythm Problems D D D I I D
Orthostatic Intolerance During Re-Exposure to Gravity D D D I I D
Crew Adverse Health Event Due To Altered Immune Response D D D I I D
Therapeutic Failure Due to Ineffectiveness of Medication D D D I I D
Adverse Health Effects Due to Alterations in Host-Microorganism Interactions D D D I I D
Performance Errors Due to Poor team Cohesion and Performance, Inadequate 
Selection/Team Composition, Inadequate Training, and Poor Psychosocial Adaptation D D D D I D
Accelerated Osteoporosis D D D D D I
Impaired Ability to Maintain Control of Vehicles and Other Complex Systems D D D D I D
Reduced Safety and Efficiency Due to Poor Human Factors Design D D D D I D
Associated with Poor Task Design D D D D I D
Error Due to Inadequate Information D D D D I D
Adverse Health Effects from Lunar Dust Exposure D D I
Performance Errors Due to Sleep Loss, Circadian Desynchronization, Fatigue, and Work 
Overload D D D D D D
Bone Fracture D D D D D D
Renal Stone Formation D D D D D D
Lunar Consequences Martian Consequences
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